Apollomics Inc. — Form SCHEDULE 13D/A
Filed August 14, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 18/100
What the filing says
Chen Yi-Kuei filed an amended Schedule 13D/A regarding Apollomics Inc. (CIK 0001944885, pharma, SIC 2834). The filing was submitted 2026-08-14 but contains no disclosed ownership percentages, share counts, dollar amounts, transaction dates, or material changes to beneficial ownership in the provided text. The document references an amendment but specific modifications are not legible in this excerpt.
Why this rating
Schedule 13D/A is routine disclosure; no quantified ownership change, transaction value, or business impact is stated in available text.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.